We are pleased to announce that effective May 5, 2020, Fidelio Capital has completed its third acquisition in the veterinary orthopedic business with an agreement to acquire a majority ownership of Veterinary Orthopedic Implants (VOI). Together, VOI, BioMedtrix and KYON form a leading global veterinary orthopedic group that complement and strengthen each other. Collectively, we now serve more than 45 markets around the world.

As a continued leader in innovation and R&D, the group is proud to now offer an even broader product portfolio that serves all customer needs. We remain committed to helping you with a best-in-class customer experience and will continue to be as dedicated as ever to our comprehensive education offering.

All routines when interacting with the companies remain unchanged; and the three brands will continue to operate as they do today. As a group, the three companies will collaborate and learn from each other in order to improve all aspects in respect to how we serve you as a customer and the overall market.

As a newly formed group with increased resources and scale, we aim to be the preferred partner to all veterinary professionals by increasing investments into R&D, education and customer service.

We thank you for your support and look forward to an even more exciting and prosperous future for all of us.